Peter Steelman is a Partner on the Biotherapeutics group at Deerfield and joined the Firm in 2013. Mr. Steelman was a co-founder of FSC Laboratories, Inc., a pediatric-focused specialty pharmaceutical company acquired by Deerfield in 2013, where Mr. Steelman had been President and CEO from 2004 through its sale in 2016. Prior to FSC, he spent 12 years in healthcare corporate and investment banking at Wachovia Capital Markets, Bank of Montreal and Citicorp. Before receiving his M.B.A. from Columbia Business School, Mr. Steelman was an equity research associate at Kidder, Peabody & Co. covering commercial banks. Mr. Steelman received his B.A. from DePauw University.
